ATAI Investor Presentation Deck slide image

ATAI Investor Presentation Deck

We are a founder-led team aiming to develop differentiated treatments for patients suffering from mental health disorders Christian Angermayer Founder & Chairman APEIRONⓇ INVESTMENT GROUP Alnylam /PHARMACEUTICALS Stephen Bardin CFO bridgebio MYOVANT SCIENCES The atai team has collectively led Florian Brand Co-Founder & CEO ROCKETINTERNET springlane 40+ Rolando Gutierrez, MD CMO Janssen Ill Bristol Myers Squibb NDAs through regulatory approval + Srinivas Rao, MD, PhD Co-Founder & CSO Depomed kyalin 140+ IND 04 applications
View entire presentation